BIOINTERVENE, INC.

Profile

Company Names

BIOINTERVENE, INC.

Addresses

C/O MPM CAPITAL, 2000 SIERRA POINT PARKWAY, SUITE 701, BRISBANE, CA 94005

550 FRONT STREET, SUITE 1605, SAN DIEGO, CA 92101

Phone Numbers

650-553-3300
619-817-9478

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$8,767,585.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-06-07 
$5,642,585.00 
$5,642,585.00 
$0.00 
Equity 
1
2019-03-12 
$3,125,000.00 
$3,125,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GARY 
J. 
BENNETT 
EXECUTIVE OFFICER, DIRECTOR
BIOINTERVENE, INC.
DAVID 
 
BREDT 
DIRECTOR
BIOINTERVENE, INC.
ED 
 
HURWITZ 
DIRECTOR
CALISTOGA PHARMACEUTICALS INC   |  SUNESIS PHARMACEUTICALS INC   |  TALIGEN THERAPEUTICS INC   |  CARA THERAPEUTICS INC   |  MACROGENICS INC   |  VIEWPOINT THERAPEUTICS, INC.   |  REKINDLE THERAPEUTICS INC.   |  BIOINTERVENE, INC.   |  ARIALYS THERAPEUTICS, INC.
GARY 
 
PATOU 
DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  KALIDEX PHARMACEUTICALS, INC.   |  BIOINTERVENE, INC.   |  BLADE THERAPEUTICS, INC.   |  STAR THERAPEUTICS LLC
DANIELA 
 
SALVEMINI 
DIRECTOR
BIOINTERVENE, INC.
SIMON 
 
TATE 
DIRECTOR
ELIEM THERAPEUTICS, INC.   |  BIOINTERVENE, INC.   |  CURASEN THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-06-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-07 
2019-03-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#